JP4712393B2 - 口内乾燥の治療に使用できる、過酸化脂質に基づく油性組成物 - Google Patents
口内乾燥の治療に使用できる、過酸化脂質に基づく油性組成物 Download PDFInfo
- Publication number
- JP4712393B2 JP4712393B2 JP2004563301A JP2004563301A JP4712393B2 JP 4712393 B2 JP4712393 B2 JP 4712393B2 JP 2004563301 A JP2004563301 A JP 2004563301A JP 2004563301 A JP2004563301 A JP 2004563301A JP 4712393 B2 JP4712393 B2 JP 4712393B2
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- silica
- composition
- lipid peroxide
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 lipid peroxide Chemical class 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims description 69
- 206010013781 dry mouth Diseases 0.000 title claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 65
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 26
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 16
- 238000005502 peroxidation Methods 0.000 claims abstract description 11
- 150000002632 lipids Chemical class 0.000 claims abstract description 6
- 238000011282 treatment Methods 0.000 claims description 13
- 239000008119 colloidal silica Substances 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 235000005687 corn oil Nutrition 0.000 claims description 5
- 239000002285 corn oil Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 3
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 2
- 235000019487 Hazelnut oil Nutrition 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 235000019485 Safflower oil Nutrition 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 239000008169 grapeseed oil Substances 0.000 claims description 2
- 239000010468 hazelnut oil Substances 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 235000011803 sesame oil Nutrition 0.000 claims description 2
- 239000008159 sesame oil Substances 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 210000000214 mouth Anatomy 0.000 description 11
- 210000005179 oral vestibule Anatomy 0.000 description 9
- 239000007921 spray Substances 0.000 description 8
- 210000002200 mouth mucosa Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 150000002978 peroxides Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000000120 Artificial Saliva Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000003079 salivary gland Anatomy 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000000518 rheometry Methods 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229910002018 Aerosil® 300 Inorganic materials 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229940041678 oral spray Drugs 0.000 description 2
- 239000000668 oral spray Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000011394 anticancer treatment Methods 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- MGIYRDNGCNKGJU-UHFFFAOYSA-N isothiazolinone Chemical compound O=C1C=CSN1 MGIYRDNGCNKGJU-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229940041672 oral gel Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940042129 topical gel Drugs 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001720 vestibular Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Description
−口腔内に使用できる抗菌剤(例えば、クロルヘキシジン)
−口腔内に使用できる任意の局所用抗真菌剤であってもよい抗真菌剤(例えば、イミジアゾール(imidiazole)を含む誘導体、接触性抗真菌性抗生物質(contact antifungal antibiotic agent))
−口腔内における上記組成物の許容性を改善するための薬剤(例えば許容因子又は緩和因子として知られる任意の成分)
−製剤の安定化剤(例えば、バッファー、増粘剤若しくは流体化剤、又は、pH中和剤)
−抗菌効果のある薬剤等の製剤の保護剤、又は、防腐剤(例えば、p−ヒドロキシ安息香酸のエステル(例えば、パラヒドロキシ安息香酸メチル、パラヒドロキシ安息香酸プロピル)又はイソチアゾリノン)
−芳香性組成物(例えば、食用香料、精油、植物又は果物の抽出物)
等の、口腔内に使用できる他の要素を更に含むことも可能であろう。
a.組成
・過酸化度50〜150ミリ等量/kgの過酸化トウモロコシ油:94.4%
・二酸化ケイ素(AEROSIL300(R)、デグサ社):1.5%
・ミント食用香料:1.0%
・オレンジ−グレープフルーツ食用香料:3.0%
・アスパルテーム:0.1%
a.試験の目的
この試験は、口内乾燥症状のある使用者について、トリグリセリド酸化物の効果を評価することからなる。
試験物質を、使用者の口腔内に、一押しで100μL分散するポンプ及びチューブを備えた装置を使用して微細な霧状でスプレーし、投与頻度は必要なだけとする。毎食後、かつ、必要となる度に、一回又は二回スプレーし、患者は、投与の度に事前に口を十分にすすぐ。
c1.使用者が実施した評価
使用者がD0において10cmのアナロジースケール(analogical scale)を使用して評価した不自由さの強度は、平均6.34である。
実験者が臨床的に観察することによって、使用者が報告した有益な効果を確認する。
Claims (11)
- 過酸化脂質及びシリカに基づく油性の口内乾燥治療用の医薬組成物であって、
過酸化度が5〜600ミリ等量/kgである過酸化脂質、及び、0.5重量%以上かつ4重量%未満の含量で前記過酸化脂質中に分散しているシリカを必須成分として含む
ことを特徴とする医薬組成物。 - シリカを0.5〜3.5重量%含む
ことを特徴とする請求項1に記載の医薬組成物。 - シリカを0.5〜2重量%含む
ことを特徴とする請求項1又は2に記載の医薬組成物。 - スプレー使用可能な形態である
ことを特徴とする請求項1〜3のいずれか1項に記載の医薬組成物。 - シリカはコロイダルシリカの形態である
ことを特徴とする請求項1〜4のいずれか1項に記載の医薬組成物。 - 組成物調製時に、毛細管粘度計を使用して測定した20℃における動的粘度が26.6〜44.4mm2/sである
ことを特徴とする請求項1〜5のいずれか1項に記載の医薬組成物。 - 密度が0.95±10%である
ことを特徴とする請求項1〜6のいずれか1項に記載の医薬組成物。 - 過酸化脂質の過酸化度が30〜500ミリ等量/kgである
ことを特徴とする請求項1〜7のいずれか1項に記載の医薬組成物。 - 過酸化脂質は、天然の脂質又は脂肪を過酸化することによって得られる
ことを特徴とする請求項1〜9のいずれか1項に記載の医薬組成物。 - 天然油は、スイートアーモンド油、ヘーゼルナッツ油、ピーナッツ油、トウモロコシ油、グレープシード油、ゴマ油及びベニバナ油、並びに、これらの混合物からなる群より選択される
ことを特徴とする請求項10に記載の医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0216517A FR2848852B1 (fr) | 2002-12-23 | 2002-12-23 | Composition huileuse a base de lipides peroxydes utilisable dans le traitement de la xerostomie |
FR02/16517 | 2002-12-23 | ||
PCT/FR2003/003861 WO2004058138A2 (fr) | 2002-12-23 | 2003-12-22 | Composition huileuse a base de lipides peroxydes utilisable dans le traitement de la xerostomie |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006513199A JP2006513199A (ja) | 2006-04-20 |
JP4712393B2 true JP4712393B2 (ja) | 2011-06-29 |
Family
ID=32406398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004563301A Expired - Lifetime JP4712393B2 (ja) | 2002-12-23 | 2003-12-22 | 口内乾燥の治療に使用できる、過酸化脂質に基づく油性組成物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8367650B2 (ja) |
EP (1) | EP1575670B1 (ja) |
JP (1) | JP4712393B2 (ja) |
AT (1) | ATE482746T1 (ja) |
AU (1) | AU2003303330A1 (ja) |
BR (1) | BRPI0317196B1 (ja) |
DE (1) | DE60334403D1 (ja) |
ES (1) | ES2358073T3 (ja) |
FR (1) | FR2848852B1 (ja) |
WO (1) | WO2004058138A2 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1902753A1 (de) * | 2006-09-19 | 2008-03-26 | Thomas Dr. Tenspolde | Spülung für den Mundinnenraum |
US9597278B2 (en) | 2008-11-13 | 2017-03-21 | David A. Hamlin | Compositions and methods for alleviating hyposalivation and for providing oral comfort |
US9884082B2 (en) | 2008-11-13 | 2018-02-06 | David A. Hamlin | Compositions and methods for alleviating hyposalivation and for providing oral comfort |
EP2367526A1 (en) * | 2008-11-13 | 2011-09-28 | VDF Futureceuticals, Inc. | Compositions and methods for alleviating hyposalivation and for providing oral comfort |
MX338801B (es) | 2011-05-16 | 2016-05-02 | Colgate Palmolive Co | Composiciones de cuidado oral. |
CN104208564A (zh) * | 2014-09-25 | 2014-12-17 | 周红玲 | 一种治疗反复性口腔溃疡的中药 |
FR3053252B1 (fr) * | 2016-06-29 | 2020-04-24 | Laboratoires Carilene | Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies |
EP3727336A1 (en) | 2017-12-20 | 2020-10-28 | 3M Innovative Properties Company | Oral compositions and methods of use |
US20220003741A1 (en) | 2018-11-16 | 2022-01-06 | Decimadx, Llc | Oral wash for oral fluid collection and analysis and methods of use thereof |
CA3194143A1 (en) | 2020-09-29 | 2022-04-07 | Decimadx, Llc | Compositions, kits and methods for collecting analyte in a saliva sample |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2591110B1 (fr) * | 1985-12-06 | 1989-02-24 | Desjonqueres Stephane | Composition medicamenteuse a base d'huile naturelle d'origine vegetale destinee a etre utilisee pour le traitement des hemorroides. |
FR2649011A1 (fr) * | 1989-07-03 | 1991-01-04 | Carilene Laboratoires | Produit medicamenteux pour la revascularisation des tissus |
FR2705568B1 (fr) * | 1993-05-27 | 1995-08-18 | Carilene Laboratoires | Utilisation de lipides peroxydés pour la préparation d'une composition pharmaceutique destinées au traitement par application locale des télangiectasies. |
FR2797584B1 (fr) * | 1999-08-16 | 2008-07-25 | Stephane Desjonqueres | Utilisation de lipides peroxydes dans le traitement ou la prevention des plaies et inflammations des muqueuses de la cavite buccale |
-
2002
- 2002-12-23 FR FR0216517A patent/FR2848852B1/fr not_active Expired - Fee Related
-
2003
- 2003-12-22 EP EP03813932A patent/EP1575670B1/fr not_active Expired - Lifetime
- 2003-12-22 AT AT03813932T patent/ATE482746T1/de not_active IP Right Cessation
- 2003-12-22 DE DE60334403T patent/DE60334403D1/de not_active Expired - Lifetime
- 2003-12-22 ES ES03813932T patent/ES2358073T3/es not_active Expired - Lifetime
- 2003-12-22 AU AU2003303330A patent/AU2003303330A1/en not_active Abandoned
- 2003-12-22 US US10/538,835 patent/US8367650B2/en active Active
- 2003-12-22 BR BRPI0317196A patent/BRPI0317196B1/pt not_active IP Right Cessation
- 2003-12-22 JP JP2004563301A patent/JP4712393B2/ja not_active Expired - Lifetime
- 2003-12-22 WO PCT/FR2003/003861 patent/WO2004058138A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20060078620A1 (en) | 2006-04-13 |
AU2003303330A8 (en) | 2004-07-22 |
FR2848852A1 (fr) | 2004-06-25 |
ATE482746T1 (de) | 2010-10-15 |
WO2004058138A3 (fr) | 2004-09-30 |
BR0317196A (pt) | 2005-11-01 |
DE60334403D1 (de) | 2010-11-11 |
US8367650B2 (en) | 2013-02-05 |
ES2358073T3 (es) | 2011-05-05 |
WO2004058138A2 (fr) | 2004-07-15 |
FR2848852B1 (fr) | 2007-03-16 |
JP2006513199A (ja) | 2006-04-20 |
AU2003303330A1 (en) | 2004-07-22 |
EP1575670B1 (fr) | 2010-09-29 |
BRPI0317196B1 (pt) | 2016-09-27 |
EP1575670A2 (fr) | 2005-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS604123A (ja) | ベンゾイン殺菌性歯用ワニス組成剤 | |
JP2005504109A5 (ja) | ||
JP4712393B2 (ja) | 口内乾燥の治療に使用できる、過酸化脂質に基づく油性組成物 | |
EA013370B1 (ru) | Средство для профилактики стоматологических заболеваний | |
Celik et al. | Do ginger extract, natural honey and bitter chocolate remineralize enamel surface as fluoride toothpastes? An in-vitro study | |
JP2005506301A (ja) | 安定した薬草入り歯磨剤 | |
KR102651050B1 (ko) | 활성 산소 화합물을 갖는 제형 및 그 적용을 위한 디바이스 | |
RU2367407C1 (ru) | Лак стоматологический | |
JP5196997B2 (ja) | 口腔用組成物 | |
Lisa et al. | The synergistic antioxidant effect and antimicrobial efficacity of propolis, myrrh and chlorhexidine as beneficial toothpaste components | |
US10813878B2 (en) | Oral health composition | |
US8337819B2 (en) | Pharmaceutical composition for the oral hygiene, the treatment of the periodontal illnesses and the halitosis | |
JP2019202968A (ja) | マトリックスメタロプロテアーゼ産生抑制用組成物 | |
US11033485B1 (en) | Dental care system containing anti-tartar and anti-plaque actives | |
EP1077061A2 (fr) | Utilisation de lipides peroxydés dans le traitement ou la prévention des plaies et inflammations des muqueuses de la cavité buccale | |
AT414095B (de) | Sialagogum auf basis einer lebensmittelsäure | |
KR20210088589A (ko) | 구강 점막 담체 및 보호제 | |
KR0179523B1 (ko) | 치은염 치료용 유향과 창출 추출물 함유 치약조성물 | |
WO2009029434A2 (en) | Anti-microbial fluoride rinses, and methods of use thereof | |
RU2355379C1 (ru) | Лечебно-профилактический эликсир и способ его получения | |
RU2376008C1 (ru) | Основа для зубной пасты | |
ES2902475T3 (es) | Composición para la prevención de crecimiento microbiano | |
RU2706010C1 (ru) | Гель стоматологический | |
FR3010635A1 (fr) | Compositions pharmaceutiques a base d'agent filmogene pour le traitement de l'hyposialie | |
RU2186561C2 (ru) | Крем для сухой и нормальной кожи лица |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20051130 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20060922 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061027 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20090227 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100601 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100831 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100928 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110127 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110214 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110308 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110323 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4712393 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |